Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 3.8M | $81.7M | $21.50 | Mar 26, 2024 | By Frazier Lifesciences Sponsor LLC |
NewAmsterdam Pharma Co N.V. | Director | Ordinary Shares | 3.01M | $64.7M | $21.50 | Mar 26, 2024 | By Frazier Life Sciences X, L.P. |
Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 5.83M | $53.1M | $9.11 | May 23, 2024 | By Frazier Life Sciences IX, L.P. |
Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 32.1K | $292K | $9.11 | May 23, 2024 | Direct |
ANAPTYSBIO, INC | Director, 10%+ Owner | Restricted Stock Unit | 3.9K | $85.1K | $21.81 | Jan 6, 2023 | Direct |
Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Common Stock | 3.91K | $35.6K | $9.11 | May 23, 2024 | Indirect |
ALPINE IMMUNE SCIENCES, INC. | Director | Common Stock | 0 | $0 | $6.33 | May 18, 2024 | By Frazier Life Sciences VIII, L.P. |
Phathom Pharmaceuticals, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 17.5K | May 23, 2024 | Direct | ||
ANAPTYSBIO, INC | Director, 10%+ Owner | Stock Option (right to buy) | 10.6K | Jan 6, 2023 | Direct | ||
ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | May 20, 2024 | Direct | ||
ALPINE IMMUNE SCIENCES, INC. | Director | Warrant (Right to Buy) | 0 | Apr 25, 2024 | By: Frazier Life Sciences VIII, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PHAT | Phathom Pharmaceuticals, Inc. | May 23, 2024 | 2 | $0 | 4 | May 24, 2024 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | May 18, 2024 | 8 | $0 | 4 | May 20, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Apr 25, 2024 | 3 | -$27 | 4 | Apr 29, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Mar 26, 2024 | 1 | $181K | 4 | Mar 28, 2024 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Director |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Dec 11, 2023 | 2 | $1.85M | 4 | Dec 13, 2023 | Director |
PHAT | Phathom Pharmaceuticals, Inc. | May 25, 2023 | 2 | $0 | 4 | May 30, 2023 | Director, 10%+ Owner |
ANAB | ANAPTYSBIO, INC | Jan 6, 2023 | 2 | $0 | 4 | Jan 10, 2023 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
PHAT | Phathom Pharmaceuticals, Inc. | Sep 22, 2022 | 1 | $0 | 4 | Sep 26, 2022 | Director, 10%+ Owner |
ANAB | ANAPTYSBIO, INC | Feb 10, 2022 | 1 | $0 | 4 | Feb 14, 2022 | Director, 10%+ Owner |
ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director, 10%+ Owner |